DRUGS MADE IN AMERICA ACQUISITION II CORP.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2025 | — | $-176.0K | $7.0K |
| Jun 2025 | — | $-214.1K | $4.4K |
| Sep 2025 | — | $-17.3M | $315.1K |
| Dec 2025 | — | $-17.8M | $223 |
| Mar 2026 | — | $-17.8M | $347.7K |
| Jun 2026 | — | $-17.9M | $175.0K |